rs397516033
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PP3_Moderate
The NM_000256.3(MYBPC3):c.3676C>T(p.Arg1226Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000217 in 1,613,716 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000256.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYBPC3 | ENST00000545968.6 | c.3676C>T | p.Arg1226Cys | missense_variant | Exon 33 of 35 | 5 | NM_000256.3 | ENSP00000442795.1 | ||
MYBPC3 | ENST00000399249.6 | c.3676C>T | p.Arg1226Cys | missense_variant | Exon 32 of 34 | 5 | ENSP00000382193.2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152196Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000482 AC: 12AN: 249220Hom.: 0 AF XY: 0.0000518 AC XY: 7AN XY: 135200
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461520Hom.: 0 Cov.: 33 AF XY: 0.0000234 AC XY: 17AN XY: 727044
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152196Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:2
- -
Variant summary: MYBPC3 c.3676C>T (p.Arg1226Cys) results in a non-conservative amino acid change located in the Immunoglobulin-like domain (IPR007110) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4.8e-05 in 249220 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in MYBPC3 causing Cardiomyopathy (4.8e-05 vs 0.001), allowing no conclusion about variant significance. c.3676C>T has been reported in the literature in individuals affected with Sudden Cardiac Death (Campuzano_2017), Cardiomyopathy (Walsh_2017, Mademont-Soler_2017) and Left Ventricular Noncompaction (Azevedo_2019), without evidence for causality. Co-occurrence with at least one other pathogenic variant has been reported (MYH7 c.2167C>G, p.Arg723Gly, Mademont-Soler_2017), providing supporting evidence for a benign role. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 31901299, 28255936, 28771489, 27532257). Six ClinVar submitters have assessed the variant since 2014, all classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -
not provided Uncertain:2
- -
Reported in multiple individuals with hypertrophic cardiomyopathy or sudden death, however, clinical details were limited and at least two patients harbored additional disease-related variants (Kassem et al., 2017; Walsh et al., 2017; Campuzano et al., 2017; Mademont-Soler et al., 2017); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27532257, 28255936, 28771489) -
Hypertrophic cardiomyopathy Uncertain:2
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 1226 of the MYBPC3 protein (p.Arg1226Cys). This variant is present in population databases (rs397516033, gnomAD 0.02%). This missense change has been observed in individual(s) with MYBPC3-related conditions (PMID: 27532257, 28255936, 31901299, 37652022). ClinVar contains an entry for this variant (Variation ID: 42731). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This missense variant replaces arginine with cysteine at codon 1226 of the MYBPC3 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in at least 5 individual affected with hypertrophic cardiomyopathy (PMID: 28771489, 27532257, doi:10.1016/j.ejmhg.2017.05.002). This variant has been identified in 12/249220 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Cardiomyopathy Uncertain:1
- -
Hypertrophic cardiomyopathy 4;C3715165:Left ventricular noncompaction 10 Uncertain:1
- -
Cardiovascular phenotype Uncertain:1
The c.3676C>T (p.R1226C) alteration is located in exon 33 (coding exon 33) of the MYBPC3 gene. This alteration results from a C to T substitution at nucleotide position 3676, causing the arginine (R) at amino acid position 1226 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at